Study Design. Retrospective analysis of a prospective, multicenter cohort study. Objective. To estimate the added effect of surgical fusion as compared to decompression surgery alone in symptomatic lumbar spinal stenosis patients with spondylolisthesis. Summary of Background Data. The optimal surgical management of lumbar spinal stenosis patients with spondylolisthesis remains controversial. Methods. Patients of the Lumbar Stenosis Outcome Study with confirmed DLSS and spondylolisthesis were enrolled in this study. The outcomes of this study were Spinal Stenosis Measure (SSM) symptoms (score range 1-5, best-worst) and function (1-4) over time, measured at baseline, 6, 12, 24, and 36 months follow-up. In order to quantify the effect of fusion surgery as compared to decompression alone and number of decompressed levels, we used mixed effects models and accounted for the repeated observations in main outcomes (SSM symptoms and SSM function) over time. In addition to individual patients' random effects, we also fitted random slopes for follow-up time points and compared these two approaches with Akaike's Information Criterion and the chi-square test. Confounders were adjusted with fixed effects for age, sex, body mass index, diabetes, Cumulative Illness Rating Scale musculoskeletal disorders, and duration of symptoms. Results. One hundred thirty-one patients undergoing decompression surgery alone (n ¼ 85) or decompression with fusion surgery (n ¼ 46) were included in this study. In the multiple mixed effects model the adjusted effect of fusion compared with decompression alone surgery on SSM symptoms was 0.06 (95% confidence interval: À0.16-0.27) and À0.07 (95% confidence interval: À0.25-0.10) on SSM function, respectively. Conclusion. Among the patients with degenerative lumbar spinal stenosis and spondylolisthesis our study confirms that in the two groups, decompression alone and decompression with fusion, patients distinctively benefited from surgical treatment. When adjusted for confounders, fusion surgery was not associated with a more favorable outcome in both SSM scores as compared to decompression alone surgery.
D
egenerative lumbar spinal stenosis (DLSS) is a narrowing of the spinal canal by surrounding bone and soft tissues that compromise neural structures. Radiographic findings of spinal stenosis are highly prevalent 1 and 85% of patients typically present with significant long-term symptoms of intermittent neurogenic claudication such as gluteal and/or lower extremity pain and fatigue that may occur with or without back pain. 2, 3 When conservative treatment fails, patients are usually referred to surgical treatment. The aim of surgery is to decompress the spinal canal and dural sac from degenerative bony and ligamentous overgrowth.
As a result, the number of surgical procedures performed for DLSS has increased steadily over the years (e.g., the rates of complex fusion surgery had a 15-fold increase between 2002 and 2007), with costs reaching USD $1.65 billion per year. 4 For instance, in the metropolitan area of Zurich with approximately 1.5 million inhabitants approximately 1750 lumbar decompression surgeries and decompression with fusion surgeries are done every year (Department of Health, Canton of Zurich, 2016, personal communication in September 2016) .
There is still a large variation in surgical management chosen by different surgeons and institutions, 5, 6 and no strong superiority of one technique over the other has been identified yet. [7] [8] [9] [10] Currently, surgical management for degenerative DLSS includes decompression with or without lumbar fusion. 11 Simple decompression surgery alone has been proven to be beneficial in patients with DLSS. [12] [13] [14] [15] Other studies showed that the addition of fusion might be valuable for patients' outcome. [16] [17] [18] The aim of the study was to estimate the added effect of surgical fusion as compared to decompression surgery alone in symptomatic lumbar spinal stenosis patients with spondylolisthesis.
MATERIALS AND METHODS

Study Design
For this retrospective analysis we did use data from the Lumbar Stenosis Outcome Study (LSOS). The LSOS is conducted as a prospective cohort study at eight medical centers (with approximately two million inhabitants in the over regional area) covered by Rheumatology and Spine Surgery Units in Switzerland. Patients with a history of neurogenic claudication and lumbar spinal stenosis verified by magnetic resonance imaging (MRI) or computed tomography were eligible. Patients had no evidence of stenosis caused by tumor, fracture, infection, or significant deformity (>158 lumbar scoliosis, diagnosed on conventional x-ray with anterior-posterior and lateral views), and were aged 50 years or more. Furthermore, patients had no clinical peripheral artery occlusive disease (confirmed by a vascular specialist in patients without palpable pulses in the lower limb). The decision of the treatment strategy (conservative or surgical) was made by the patient and his attending physician. Patients were assessed for eligibility between December 2010 and December 2015, and will be followed up 3 years.
Patient Population
All patients who met inclusion criteria, underwent surgery on one or two adjacent levels with degenerative spondylolisthesis (DS, step >3 mm, evaluated in MRI, flexion-extension radiographs were not obtained), and had at least 12 months follow-up were eligible. Furthermore, none of the patients had prior lumbar spine surgery.
Surgical Interventions
All patients underwent either decompression alone (decompression alone group) or decompression with fusion (fusion group). Decompression surgery consisted of a standard open or microscopic posterior lumbar decompression of the affected level(s). Decompression of the lateral recess and the foramina was performed when necessary to decompress the exiting nerve roots. Fusion surgery consisted besides decompression surgery of additional implantation of pedicle screws with rods, and intersomatic fusion and cage(s) at the affected level(s). The decision to add fusion and to proceed with single compared with multilevel procedures was based on the surgeon's discretion. The procedures were done or supervised by senior neuro-or orthopedic surgeons with more than 10 years of experience after board certification.
Radiological Classification
The MRI of each patient was evaluated by two senior radiologists. They categorized the severity of the central stenosis of each level into ''no,'' ''mild,'' ''moderate,'' or ''severe,'' and lateral recess and foraminal stenosis into grade 0 to 3 according to the consensus paper on core radiological parameters of the LSOS. 19 
Data Collection and Follow-up
Parts of the basic data sheet were interview-administered and recorded by a study coordinator. All other questionnaires were self-administered and completed by the patients themselves. All data were collected at baseline, and at 6 months. Long-term outcome data were gathered after 1, 2, and 3 years.
The study coordinator checked all questionnaires after receiving for completeness. In case of missing data, he called the patient and tried to collect the missing data.
Data were entered independently and in duplicate in two databases that were crosschecked. Any discrepancies were identified and rechecked in the original files.
Questionnaires
Spinal Stenosis Measure (SSM): The SSM, an instrument specifically developed for spinal stenosis patients by Stucki et al, 20 targets to measure severity of symptoms and quantifies disability of the lumbar spinal stenosis population. It is recommended by the North American Spine Society and used in different studies on lumbar spinal stenosis. [21] [22] [23] [24] It consists of three different subscales; the Symptom Severity Subscale, the Physical Function Subscale, and the Satisfaction Subscale. The symptom severity scale can be divided into a pain domain (severity, frequency, and back pain) and a neuroischemic domain (leg pain, weakness, numbness, and balance disturbance). Score range is from 1 to 5 and 1 to 4 (best-worst), respectively.
Feeling Thermometer and Numeric Rating Scale: General assessment of lumbar spinal stenosis symptoms such as lower extremity pain and discomfort are measured. Score range is from 0 to 100 and 0 to 10 (best-worst), respectively.
EQ-5D-3L: The EQ-5D-3L is an assessment tool to measure health-related quality of life. It measures general non-disease-specific health-related quality of life, including physical, mental, and social dimensions. 25 The health status measures five dimensions of health (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), which can be calculated as a sum score (score range 0-100, worst-best). 25 The second part of the questionnaire estimates patient's actual health status (score range 0-100, worst-best).
Roland and Morris Disability Questionnaire (RMDQ): The RMDQ is a back pain-specific, self-rated physical disability questionnaire developed by Roland and Morris in 1983. 26 Disability is measured with respect to the following categories: physical function activities and activities of daily living including eating and sleeping. Score range is from 0 to 24 (best-worst).
Cumulative Illness Rating Scale (CIRS): Comorbidity is measured using CIRS that rates the presence and severity of comorbid diseases in 14 organ systems (according to modified version by Miller et al 27 ). Score range is from 0 to 56 (best-worst). The musculoskeletal organ system (CIRS musculoskeletal disorders) was separately included in the analysis. Score range is from 0 to 4 (best-worst).
Outcomes
The outcomes of this study were SSM symptoms and SSM function over time. These outcomes were measured at baseline, 6, 12, 24, and 36 months follow-up.
Further outcomes of interest were Numeric Rating Scale, Feeling Thermometer, EQ-5D-EL sum score and actual health status, and RMDQ at 12 months follow-up.
Ethics
This multicenter cohort study was conducted in compliance with all international laws and regulations and any applicable guidelines. Written informed consent to participate in the study has been obtained from participants. The study was approved by the independent Ethics Committee of the Canton Zurich (KEK-ZH-NR: 2010-0395/0).
Sample Size Considerations
We calculated that a minimum of 44 patients with baseline and 12 months follow-up in each treatment group-the decompression alone group and fusion group-would be required for the study to have 80% power to detect a clinical relevant difference in change in SSM symptoms of 0.48 at a significance level of 0.05. 20 The standard deviation (SD) was assumed to be 0.8 (Ulrich et al., 28 accepted for publication in Clinical Spine Surgery) in both treatment groups. Imbalance in baseline characteristics between treatment groups were adjusted for within the regression framework.
Statistical Analyses
Analysis of data consisted of descriptive statistics of patient demographics and outcomes at baseline. Continuous variables were shown as mean and SD, and categorical variables were shown as numbers and percentages of total, stratified by decompression alone and decompression with fusion. Scatterplots were used to display changes in main outcomes over follow-up time and to display the correlation structure of the repeated measurements over time.
In order to quantify the effect of fusion surgery as compared to decompression alone and number of decompressed levels, we used mixed effects models and accounted for the repeated observations in main outcomes (SSM symptoms and SSM function) over time. In addition to individual patients' random effects, we also fitted random slopes for follow-up time points and compared these two approaches with Akaike's Information Criterion (AIC) and the chi-square test. Confounders were adjusted for with fixed effects for age, sex, body mass index (BMI), diabetes, CIRS musculoskeletal disorders, and duration of symptoms. Continuous confounders were centered before inclusion to simplify interpretation of the intercept term. Conservative P values for the fixed effects were calculated as proposed by Kenward and Roger. 29 The level of significance was set to 5%.
All analyses were conducted with R for Windows. 30 
RESULTS
Patient Characteristics
Between December 2010 and December 2015 approximately 1716 patients were potentially eligible, 853 patients agreed to participate, and 724 patients had no prior lumbar spine surgery ( Figure 1 , study flow). Of these, 443 patients underwent decompression surgery alone or decompression with fusion surgery within the first 6 months after baseline. For this study, 131 patients met the inclusion criteria ( Figure 1 ). In Table 1 we present the patients' baseline characteristics; 85 (65%) patients underwent decompression alone and 46 (35%) patients underwent decompression with fusion. Baseline characteristics were remarkably similar; however, patients in the fusion group were slightly younger (mean age 68 vs 75.4 yr in the decompression alone group). There were no other statistically significant differences in baseline characteristics.
Overall, 76 of 131 patients (58%) were women, and mean BMI was 26.8 kg/m 2 (SD 4.5). Seventeen patients had diabetes (13%) and 23 (17.6%) were current smokers. Fiftytwo patients (61.2%) had previous lumbar epidural steroid injections in the decompression alone group, and 28 patients (60.9%) in the fusion group.
Four variables (duration of symptoms, EQ-5D-EL sum score and actual health status, and RMDQ) had a small percentage of missing values at baseline and/or 12 months follow-up (ranging from 0.75% to 1.5%).
Surgical Characteristics
Most patients in both groups were operated on the L4/L5 level (84.7% in the decompression alone and 82.6% in the fusion group, respectively). Furthermore, no patient had surgery on the level L1/L2. In the decompression alone group, 83.5% of the patients were operated microscopically, whereas in the fusion group only 54.3% of the patients were operated microscopically ( Table 2 ).
In the decompression alone group, most patients had three or four moderate-or severe-level stenoses (31.8% and 30.6%, respectively), and 20% had two. In the fusion group, 28.3% of the patients had three moderateor severe-level stenoses, 26.1% had two, and 28.3% had one (Table 2 ).
In the fusion group, 39 patients were treated with transpedicular screws with rods and intersomatic cages, and 
Intra-and Postoperative Complications, Reoperations
Two patients (2.4%) in the decompression alone group and one patient (2.2%) in the fusion group experienced a durotomy during the surgery (Table 3) . No patient in the decompression alone group and one patient (2.2%) in the fusion group had a postoperative wound infection. Other postoperative complications (e.g., urosepsis, hemorrhage, wound healing deficit) were seen in 6% and 6.6% of the patients, respectively. None of these differences were statistically significant. Furthermore, no patient died within 6 months postoperatively.
Reoperations were performed in eight patients (9.4%) in the decompression alone group (one patient underwent two reoperations) and two patients (4.3%) in the fusion group (Table 3) . Mean time to the second surgery was 192 days (range 8-565) in the decompression alone group and 280 days (range 33-527) in the fusion group. Six (75%) of the initially decompressed only patients underwent a fusion procedure during second surgery.
Further Outcomes at 12 Months Follow-up
All patients improved from baseline to 12 months follow-up (Appendix Table 1 , http://links.lww.com/BRS/B248). The patients of the fusion group improved more than the patients in the decompression alone group; however, factors influencing the treatment decisions were not accounted for these raw data.
Repeated Measurements Analysis for Main Outcomes
Spinal Stenosis Measure Symptoms Graphical display of SSM symptoms from baseline to 36 months revealed a strong overall decrease from baseline to 6 months, a slighter decrease from 6 to 12 months, and remained fairly constant on the low level up to 36 months (Figure 2A, left) , as depicted by the corresponding loess curve. The pattern of the fusion group was similar to the overall trend, whereas there was a slight increase in the decompression group between 12 and 36 months (Figure 2A ; right and center).
The mixed effects model was fitted with random patient effects and with random slopes over time. When comparing the models, the AIC was in favor of the more complex random slopes model (chi-square P < 0.001). Table 4 shows the adjusted effect of fusion compared with decompression alone surgery on SSM symptoms, which is estimated to be . 20 The confounders were 2-versus 1-level decompression surgery, age, sex, BMI category, diabetes, CIRS musculoskeletal disorder subscore, and duration of symptoms before baseline in this model. Estimated random effects (bullet points) and slopes (small lines) were plotted against age at baseline in Appendix Figure 2 . A, SSM symptoms score is displayed against time. The size of the bubbles represents the number of patients with the specific SSM symptoms score value. The overall trend is displayed by the solid black line, a smoothed estimate of the overall trend. The left most figure is based on all patients, the middle figure is based on patients with decompression alone, and the right most figure is based on patients with fusion. B, SSM function score is displayed against time. The size of the bubbles represents the number of patients with the specific SSM function score value. The overall trend is displayed by the solid black line, a smoothed estimate of the overall trend. The left most figure is based on all patients, the middle figure is based on patients with decompression alone, and the right most figure is based on patients with fusion. SSM indicates Spinal Stenosis Measure. Figure 1a , http://links.lww.com/BRS/B248. It showed that older patients with higher levels of SSM symptoms developed slightly less favorable than the general decreasing trend.
Spinal Stenosis Measure Function
Graphical representation of SSM function showed an overall decrease from baseline to 36 months ( Figure 2B, left) . A similar pattern as in SSM symptoms was visible in the clinical courses across patients with fusion and decompression alone surgery ( Figure 2B , right and center). When we fitted two mixed effects models, one with random patient effects and one with random slopes over time, we found that the AIC was smaller for the more complex model (chi-square P ¼ 0.048). The estimated effect of fusion compared with decompression alone surgery on SSM function was À0.07 (95% CI: À0.25-0.10) ( Table 5 ) when adjusting for the confounders 2-compared with 1-level decompression surgery, age, sex, BMI category, diabetes, CIRS musculoskeletal disorder subscore, and duration of symptoms before baseline. On average, patients improved (decreased) by 0.66 points in SSM function from baseline to 6 months follow-up. Improvement over time increased at 12, 24, and 36 months (0.79, 0.75, 0.71 points, respectively). The improvement considered clinically meaningful is 0.52 points for SSM function. 
DISCUSSION
The present study examined the effect of decompression alone compared with decompression with fusion surgery in patients with symptomatic DLSS and DS. Our results demonstrated that both groups distinctly benefited from surgical treatment and the positive effect persisted over 3-year follow-up period. When adjusted for confounders, fusion surgery was not associated with a more favorable outcome in both SSM scores as compared to decompression alone surgery.
Our results were in line with a quite recently published randomized controlled trial (RCT) by Forsth et al. 15 In their trial the baseline SSM symptoms and function scores were comparable to our patient groups and after 2 years followup, they reported no significant differences in both scores between decompression surgery with fusion and decompression alone surgery in patients with DS. In a retrospective study from 2013 with more than 5390 patients (with and without spondylolisthesis) by Forsth et al, 31 the authors identified no patient-reported differences between the decompression only group and the fusion group 2 years postoperatively. Athiviraham et al 32 came to a similar conclusion in their cohort study with 96 patients at 2 years follow-up.
Ghogawala et al, 18 on the contrary, reported in their RCT a significantly greater and clinically meaningful improvement in patients with DS who underwent decompression with fusion compared with decompression alone. These results are in contrast to our findings; however, they reported an improvement only in the physical-component summary of the Medical Outcomes Study 36-Item ShortForm Health Survey (SF-36). The SF-36 is a generic outcome measure that does not measure specific neuroischemic features of DLSS, which may be the dominant symptoms. 33 Furthermore, more patients underwent reoperation in the decompression alone group. This might have had a negative effect on the physical-component summary score of SF-36 during the time from initial to secondary surgery.
Fusion surgery is associated with increased risk of major complications (i.e., acute myocardial infarct, respiratory failure, pneumonia) 4 and higher infection rates due to osteosynthesis material. Furthermore, the longer operating times of fusion compared with decompression alone surgery increase the risks of anesthesia and their consequences in the typical elderly lumbar spinal stenosis patient population. In these patients osteopenia or osteoporosis is also a common concomitant disease that increases the risk of screw loosening and sinking of the intersomatic cage. Nevertheless, surgeons use more and more fusion procedures 4 with the aim of preventing possible postoperative instability-especially if DS is present-despite the lack of a broadly accepted definition of this term. 34 The approach of treating patients with DS with decompression and fusion is based on the results of a landmark study by Herkowitz and Kurz 17 from 1991 and subsequent long-term results of the same cohort. 35 This cohort was, however, small (n ¼ 50), not randomized, did not address potential confounders or different techniques of fusion, and did not use validated measures of treatment success. Moreover, only little new evidence has emerged to justify the increased risks and costs that are associated with fusion since these studies. 36 Fusion procedures are also associated with increased resource use. 4 Costs of fusion surgery are twice as expensive in Switzerland (diagnosis-related groups, SwissDRG standard treatment costs) and the estimated hospital stay is longer.
The main strength of the present study was that only patients who underwent surgery on one or two adjacent levels and DS were included. The present study was designed to give us the opportunity to evaluate the effect of decompression alone compared with decompression with fusion surgery very specifically. The mixed models approach did adjust for the differences in age and other potential confounders at baseline, which otherwise would have affected the results. Display of ''raw'' data might be useful for understanding differences in outcomes. As in nonrandomized studies it does not, however, account for systematic differences between treatment groups (with respect to covariates like age, BMI, etc.), it might also be misleading or even giving a biased impression. Further advantages of the LSOS include the multicenter setting and prospective collection of data, and the use of established questionnaires on DLSS.
A limitation of the present study was that the treatment strategy (with or without fusion) was not randomized. If unaccounted for, this could have led to biased estimate of the effect of fusion. To account for this problem, adjustment for potential confounding was performed, however, only for measured covariates. Consequently, unmeasured confounders could have affected the difference between the two groups and hampered direct comparisons with RCTs. Other limitations of the study were its small sample size and that only a third of the included patients have already reached 36 months follow-up. In addition, we do not have any data regarding operating time, length of hospital stay, or the bone matrix density. These parameters might have influenced our results.
CONCLUSION
Among the patients with DLSS our study confirms that in the two groups, decompression alone and decompression with fusion, patients distinctively benefited from surgical treatment. When adjusted for confounders, fusion surgery was not associated with a more favorable outcome in both SSM scores as compared to decompression surgery alone.
Key Points
Aim of the present study was to assess which surgical management provides better outcome in degenerative spinal stenosis cases with spondylolisthesis: decompression alone or decompression with fusion. The LSOS is conducted as a prospective cohort study at eight medical centers with approximately two million inhabitants in the over regional area. One hundred thirty-one patients undergoing decompression surgery alone (n ¼ 85) or decompression with fusion surgery (n ¼ 46) were included in the present study. In the multiple mixed effects model the adjusted effect of fusion compared with decompression alone surgery on SSM symptoms was 0.06 (95% CI: À0.16-0.27) and À0.07 (95% CI: À0.25-0.10) on SSM function, respectively. When adjusted for confounders, fusion surgery was not associated with a more favorable outcome in both SSM scores as compared to decompression alone surgery.
